First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
The agency changed course just days after firing employees who oversee the safety of food and life-sustaining medical devices ...
“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...